Mail

UK markets closed

FTSE 100
8,139.83
+60.97(+0.75%)
FTSE 250
19,824.16
+222.18(+1.13%)
AIM
755.28
+2.16(+0.29%)
GBP/EUR
1.1679
+0.0022(+0.19%)
GBP/USD
1.2494
-0.0017(-0.13%)
Bitcoin GBP
50,420.39
-1,021.84(-1.99%)

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Evolent Health, Inc. (EVH)

NYSE - NYSE Delayed price. Currency in USD

Add to watchlist

27.65

-0.67

(-2.37%)

At close: 04:00PM EDT

27.65

0.00

(0.00%)

After hours:

04:53PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	3.15B
Enterprise value	3.60B
Trailing P/E	N/A
Forward P/E	19.96
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	1.57
Price/book (mrq)	2.95
Enterprise value/revenue	1.83
Enterprise value/EBITDA	-145.29

Trading information

Stock price history

Beta (5Y monthly)	1.54
52-week change ³	-24.12%
S&P500 52-week change ³	22.36%
52-week high ³	36.70
52-week low ³	23.33
50-day moving average ³	31.74
200-day moving average ³	29.37

Share statistics

Avg vol (3-month) ³	919.79k
Avg vol (10-day) ³	835.4k
Shares outstanding ⁵	113.89M
Implied shares outstanding ⁶	117.67M
Float ⁸	109.13M
% held by insiders ¹	4.17%
% held by institutions ¹	112.16%
Shares short (15 Apr 2024) ⁴	11.38M
Short ratio (15 Apr 2024) ⁴	15.08
Short % of float (15 Apr 2024) ⁴	11.72%
Short % of shares outstanding (15 Apr 2024) ⁴	9.99%
Shares short (prior month 15 Mar 2024) ⁴	10.81M

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	-5.76%
Operating margin (ttm)	1.23%

Management effectiveness

Return on assets (ttm)	0.86%
Return on equity (ttm)	-10.74%

Income statement

Revenue (ttm)	1.96B
Revenue per share (ttm)	17.65
Quarterly revenue growth (yoy)	45.40%
Gross profit (ttm)	N/A
EBITDA	127.5M
Net income avi to common (ttm)	-142.26M
Diluted EPS (ttm)	-1.28
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	192.82M
Total cash per share (mrq)	1.69
Total debt (mrq)	644.8M
Total debt/equity (mrq)	51.74%
Current ratio (mrq)	1.01
Book value per share (mrq)	9.38

Cash flow statement

Operating cash flow (ttm)	142.58M
Levered free cash flow (ttm)	172.48M